Acurx Pharmaceuticals, Inc.

  • Home
  • About
    • Management / Consultants
    • Scientific / Corporate Advisors
    • Board of Directors
  • Pipeline
    • Overview
    • Ibezapolstat
    • GPSS®
    • Publications
  • News & Media
    • Press Releases
    • Presentations
    • Videos
  • Investors
    • Overview
    • News / Events
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • Contact

ALERT: NEW ARTICLE

New England Journal of Medicine , “One Pivotal Trial, the New Default Option for FDA Approval – Ending the Two-Trial Dogma,” by Vinay Prasad, M.D., M.P.H.1 and Martin A. Makary, M.D., M.P.H.1

Read Publication

Continue

IR Calendar

Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Balance Sheet
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • Investor Tools
    • Email Alerts
    • Contacts
    • RSS News Feed

  • News / Events

  • Overview
  • Press Releases
  • IR Calendar
  • Email Alerts

Fourth Quarter Financial Results Conference Call

Mar 13, 2026 • 8:00am EDT
PDF HTML
Earnings Release
PDF HTML
10-K Filing
ZIP HTML
XBRL
© 2026 Acurx Pharmaceuticals, Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap